A Multifaceted Evaluation of National Off-label Neurology Applications


Yurtogullari S., Rahmanlar H., Alkan A., Bayar B., Gursoz H., UZUN ADATEPE N.

TURKISH JOURNAL OF NEUROLOGY, vol.26, no.3, pp.235-241, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 3
  • Publication Date: 2020
  • Doi Number: 10.4274/tnd.2020.37791
  • Journal Name: TURKISH JOURNAL OF NEUROLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.235-241
  • Istanbul University Affiliated: No

Abstract

Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey.